These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 2472451)

  • 1. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
    Tocci MJ; Matkovich DA; Collier KA; Kwok P; Dumont F; Lin S; Degudicibus S; Siekierka JJ; Chin J; Hutchinson NI
    J Immunol; 1989 Jul; 143(2):718-26. PubMed ID: 2472451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    Tao X; Davis LS; Hashimoto K; Lipsky PE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by anti-HLA class II monoclonal antibodies of monoclonal antibody OKT3-induced T cell proliferation. Studies at the mRNA level.
    Racioppi L; Moscarella A; Ruggiero G; Manzo C; Ferrone S; Fontana S; Zappacosta S
    J Immunol; 1990 Dec; 145(11):3635-40. PubMed ID: 1978847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes.
    Borger P; Kauffman HF; Vijgen JL; Postma DS; Vellenga E
    Exp Hematol; 1996 Feb; 24(2):108-15. PubMed ID: 8641331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of transforming growth factor-beta on early and late activation events in human T cells.
    Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
    J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506 and rapamycin selectively enhance degradation of IL-2 and GM-CSF mRNA.
    Hanke JH; Nichols LN; Coon ME
    Lymphokine Cytokine Res; 1992 Oct; 11(5):221-31. PubMed ID: 1281674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
    June CH; Ledbetter JA; Lindsten T; Thompson CB
    J Immunol; 1989 Jul; 143(1):153-61. PubMed ID: 2543699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression.
    Han CW; Imamura M; Hashino S; Zhu X; Tanaka J; Imai K; Matsudaira T; Asano S
    Bone Marrow Transplant; 1995 May; 15(5):733-9. PubMed ID: 7545487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early immune response and regulation of IL-2 receptor subunits.
    Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
    Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells.
    Staruch MJ; Camacho R; Dumont FJ
    Cell Immunol; 1998 Dec; 190(2):121-31. PubMed ID: 9878113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressants FK506 and rapamycin have different effects on the biosynthesis of cytoplasmic actin during the early period of T cell activation.
    Miyamoto S; Safer B
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):803-12. PubMed ID: 10585867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
    Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
    J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7 enhances the expression of IL-3 and granulocyte-macrophage-CSF mRNA in activated human T cells by post-transcriptional mechanisms.
    Dokter WH; Sierdsema SJ; Esselink MT; Halie MR; Vellenga E
    J Immunol; 1993 Apr; 150(7):2584-90. PubMed ID: 8454845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones.
    Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA
    J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
    Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
    J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
    Han SB; Park SH; Jeon YJ; Kim YK; Kim HM; Yang KH
    J Pharmacol Exp Ther; 2001 Nov; 299(2):415-25. PubMed ID: 11602650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms.
    Borger P; Kauffman HF; Postma DS; Vellenga E
    J Immunol; 1996 Feb; 156(4):1333-8. PubMed ID: 8568231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors.
    Iñiguez MA; Punzón C; Fresno M
    J Immunol; 1999 Jul; 163(1):111-9. PubMed ID: 10384106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.
    Mortellaro A; Songia S; Gnocchi P; Ferrari M; Fornasiero C; D'Alessio R; Isetta A; Colotta F; Golay J
    J Immunol; 1999 Jun; 162(12):7102-9. PubMed ID: 10358154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.